According to Igor Laskowski, MD, vascular surgery leader at Westchester Medical Center and principal investigator of the trial: “There is an imperative need for effective therapies. We are a think tank here at Westchester Medical Center and we hope that the Phase II examination of BioGenCell – and many other ongoing studies at our hospital – will enable the diagnosis of patients affected by this and other debilitating diseases. “
Dr. Salomon Amar, vice president of research at Touro University and NYMC, added, “We are inspired by the effects of BioGenCell to date and are pleased to have our training hospital, Westchester Medical Center, participate in this trial. This is especially gratifying for Touro. collaborate with an Israeli company. “
People with ITLC and interested physicians are invited to visit www. biogencelltrial. com or contact the study coordinator (details) for more information on how to participate in the clinical trial.
BioGenCell, founded at Laniado Hospital in Netanya, Israel, is committed to the lives of patients suffering from degenerative microvascular diseases. BioGenCell aims to expand its success to treat a greater diversity of vascular and other diseases in the future. For more information, please stop at https://www. biogencell. net.
Westchester Medical Center Health Network (WMCHealth) is a 1,700-bed fitness formula based in Valhalla, New York, with nine hospitals on seven campuses spanning 6,200 square miles of the Hudson Valley. WMCHealth employs more than 13,000 people and has approximately 3,000 attending physicians. The Network has Level I (adult and pediatric), Level II and III trauma centers, the only juvenile acute hospital in the region, an educational medical center, several network hospitals, dozens of institutes and specialized centers, comprehensive care and number one care centers, qualified nursing centers, assisted living facilities, etc. , home care and one of the largest intellectual fitness formulas in New York State. Today, WMCHealth is the leading provider of incorporated physical care in the Hudson Valley. For more facts about WMCHealth, stop at WMCHealth. org or stay at WMCHealth in Facebook. com/WMCHealth or Instagram. com/WMCHealth.
View content: https://www. prnewswire. com/news-releases/westchester-medical-center-and-biogencell-open-biogencells-fourth-chronic-limb-menacing-ischemia-clinical-trial-site-in-les -etats-. -301918092. html
SOURCE BioGenCell